Certara Second Quarter 2023 Earnings: Revenues Disappoint

In this article:

Certara (NASDAQ:CERT) Second Quarter 2023 Results

Key Financial Results

  • Revenue: US$90.5m (up 9.3% from 2Q 2022).

  • Net income: US$4.71m (up from US$589.0k loss in 2Q 2022).

  • Profit margin: 5.2% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue.

  • EPS: US$0.03 (up from US$0.004 loss in 2Q 2022).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Certara Earnings Insights

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in the US.

Performance of the American Healthcare Services industry.

The company's shares are down 10% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Certara's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement